Ornithine Decarboxylase in Skin  by Lesiewicz, Jeanne & Goldsmith, Lowell A.
0022-202X/ 80/ 7503-0207$02.00/ 0 
THE JOURNAL OF i NVESTIGATI VE DERMATOLOGY, 75:207-210, 1980 
Copyright © 1980 by The Williams & Wilkins Co. 
Vol. 75, No.3 
Printed in U. S.A. 
REVIEW ARTICLE 
Ornithine Decarboxylase in Skin 
JEANNE LESIEWICZ, PH.D., AND LOWELL A. GOLDSMITH, MD 
Division of Dermatology, Department of Medicine, Duhe University Medical Center, Durham., North Carolina, U.S.A. 
Ornithine decarboxylase (ODC) was discovered in an-
imal tissues in 1968 [1,2] and interest in its activity and 
regulation has led to a rapidly and still expanding liter-
ature on the enzyme. Several comprehensive reviews 
have already appeared [3-6]. This article emphasizes our 
current knowledge of ODC in mammalian skin. The in-
volvement of ODC in tumor promotion will be discussed 
only briefly, since several recent monographs review 
this subject [7]. The extensive literature on ODC in tissue 
culture systems will be omitted for the sake of brevity. 
Ornithine decarboxylase is the first enzyme in the 
biosynthetic pathway for the polyamines, putrescine, 
spermidine and spermine (Fig. 1). Putrescine is the im-
mediate product of ODC; and spermidine and spermine 
are synthesized from putrescine by the addition of ami-
nopropyl groups generated by the enzyme S-adenosyl-L-
methionine decarboxylase. The polyamines spermidine 
and spermine are polycationic molecules which interact 
strongly with nucleic acids. Polyamines stabilize the 
structure of both DNA and RNA and also participate in 
many enzymatic reactions involving nucleic acids, such 
as transfer RNA aminoacylation, protein synthesis and 
RNA transcription [4,5]. Intracellular levels of polya-
mines and their biosynthetic enzymes are generally 
found to correlate with growth, though a cause and effect 
relationship has not been proven. Since ODC is the rate-
limiting enzyme for polyamine synthesis, its control has 
been of prima ry interest and importance in most studies. 
BIOCHEMISTRY 
L-ornithine is synthesized in skin fro m arginine by the en-
zyme arginase. D eterminations in the rat, guinea pig and man 
s how that it represents 0.25 to 6.42 mole % of the free amino 
acids in skin [8]. ODC is a cytosol enzyme that enzymatically 
removes C02 at the 1 position ofL-orni thine to yield putrescine. 
P utrescine and C0 2 are formed with a 1:1 sto ichiometry [1,9]. 
ODC activity is generally assayed by measuring the release of 
14CO~ from [1-1"C]-ornithine. The enzyme does not require 
metal ions and has an optimum pH of 7.0-7.3 depending on the 
buffer. The K"' for L-ornithine varies from 0.026-0.19 mM, 
d epending on the sou1·ce and pw·ity of the enzyme (1,10,11]. 
ODC activity is inhibited by its product, putrescine, and by a 
variety of product and substrate analogues including spermidine 
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and spermine. Low concentrations of pu trescine (2 J.LM) result in 
competit ive inhibition [1], but at higher concentrations (10 mM) 
inhibition becomes noncompetitive (11]. 
Pyridoxal phosphate is required for enzymatic activity, with 
an apparent Km ofO.l mM [11]. Inhibitors of pyridoxal-requiring 
enzymes (e.g. isonicotinic acid hydrazide and 4-bromo-3-hy-
droxybenzloxamine) inhibi t mam malian ODC activity [1). 
Binding of the L-ornithine substra te to the active site takes 
place tlu-ough Schiff base formation with enzyme-bound pyri-
doxal phosphate. The irreversible inhibition of ODC activity 
seen with cer tain substrate analogues requires Schiff base com-
plexing of the inhibitor with pyridoxal phosphate in t he en-
zyme's active site [12). The noncompetit ive inhibition of ODC 
activi ty seen at high concentrations of putrescine or its ana-
logues appears to result from competit ion for pyridoxyl phos-
phate by the enzyme and the polya mine. 
Dithiothreitol, at a concentration of 5 mM , is also required 
for optima] ODC enzymatic activi ty. Monothiol reducing 
agents, including reduced glutathione, a major reducing agent 
in skin, are considerably less effective. In the absence of added 
thiols, ODC apperu·s to undergo polymerization to larger, often 
inactive forms [10). When isolated and chmmatographed in the 
presence ofO.l mM pyridoxal phosphate and 5.0 mM dithiotlu-e-
itol, ODC from rat skin elutes fro m a calibrated Biogel-P!OO 
column with an estimated molecu lar weight of 52,000 (J. Les-
iewicz and L.A. Goldsmith, unpublished observations) . 
ODC IN NORMAL SKIN 
The activity of orn ithine decarboxylase is generally high in 
rapidly proliferating cells. Fetal t issues and organs possess high 
ODC activity, which then decreases postnatally [4]. No data is 
yet available on ODC levels in fetal periderm, epidermis or 
whole skin. ODC activity is generally reported as specific activ-
ity per mg protein and has not been correlated with cell num-
bers or the number of cells in pruticular cell layers. St4dies in 
rat dorsal whole skin indicate that basal ODC activity decreases 
p1~ogressively as the anin1als grow from pre-weanling to yo ung 
adul t [9). Pre-weanling mice aTe found to exhibit a tran ient 
increase in skin ODC in response to subcutaneous injection of 
epidermal growth factor [13). 
Basal ODC activity (per mg soluble protein ) is higher in the 
dermis t han in the epidermis [9]; presumably most of t he 
dermal ODC is follicular in origin . In hair follicl es, ODC activity 
correlates posit ively with the cyclic growth of hair, wi th mini-
mal activity found during the resting phase [14]. Both folliculru· 
and interfolliculru· epidermal ODC activit ies are stimulated by 
plucking of telogen hairs. ODC activity decreases ini tia lly, then 
rises to peak levels 4 hr after hair plucking. A high level of 
activity is maintained for at least 12 ru· after plucking [9,14,15]. 
As reported for other mammalian organs, ODC from sk in has 
a unusually short biological half-life. In unstin1Uiated whole 
dorsal rat skin extracts, ODC exhibi ts a half-life of 29.5 min. 
Stimulation of skin ODC activi ty by hair plucking results in an 
approximate doubling of the enzyme's half-life to 54.0 min (15]. 
T he response of rat skin ornithine decarboxylase to nutri-
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FIG I. B iosynthetic pathway for t he polyamines. E nzymes indicated 
by an asterisk (*) have been reported in mammalian skin. 
tiona! alterations has been studied. When rats are fed diets 
containing from 2 to 24% protein for 4 or 8 days, the level of 
ODC activity in both unstimulated and plucked skin is found 
to increase with increasing dietary protein. Rehabilitation with 
16% protein diet after 7 days of a 2% protein diet indicates that 
ODC enzyme activity increases over 5 days to levels near or 
slightly higher than controll6% protein diet levels [9]. Further 
experiments have determined that both unstimulated and 
plucked skin ODC activity levels are maintained for up to 24 hr 
of starvation, followed by significant decreases below fed con-
trols. Under th ese condi tions the half-life of unstimulated ODC 
is reduced to 1-3.2 min . Following 24 hr of starva tion, refeeding 
of complete diet for 12· or 24 hr restores ODC enzyme activity 
to fed control levels (J . Chain, J . Lesiewicz and L.A. Goldsmith, 
unpublished observations) . Refeeding of protein deficient diets 
for up to 24 hr does not restore unstimulated or stimulated 
ODC activity to control levels, and stimulated ODC activity 
appears to correlate with dietary protein levels (J . Lesiewicz, 
D. Morrison and L. A. Goldsmith, _unpublished observations). 
Skin ODC activity is stimulated by wounding. In rat whole 
skin wounded by punch biopsy,'ODC activi ty levels rise rapidly 
to a maximum 12 hr later. Enzyme activity returns to basal 
levels by 48 h.r [16]. Similar .results are seen in mouse epidermis 
wounded by eith er multiple cuts ·or abrasion. Maximal ODC 
activity is detected 20-26 hr after wounding and a secondary 
rise occurs at 72 lu [17]. Administration of the synthetic glu-
cocorticoid, betamethasone, delays the rise in ODC activity in 
wounded skip [16]. The delay of wound healing produced by 
topical treatment of skin with the drug Furacin, may result 
from inhibition of ODC induction [18]. 
ODC IN HYPERPLASIA AND DISEASE 
Irradiation of hairless mice with ultraviolet light of wave-
lengths 290 to 320 nm (UVB) produces thickening of the epi-
dermis within 48 hr. ODC activity in UVB-in:adiated epidermis 
begins to increase within 2 hr after irradiation and reaches a 
peak 250 to 350-fold greater than unirradiated controls after 28 
hr. Enzyme activity declines to near control levels after 48 hr. 
The increase in ODC activity resulting from UVB exposure is 
dose dependent and is inhibited by both cycloheximide ami 5-
azacytidine, indicating a requirement for de novo protein and 
RNA synthesis [19]. The anti-inflammatory glucocorticoids 
triamcinolone acetonide, and fluo cinolone acetonide and the 
prostaglandin cyclooxygenase inhibitor, indomethacin, are ef-
fective inhibitors of UVB induction of ODC activi ty in mouse 
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epidermis. Inhibit ions of 50% or greater are seen at doses 
between 0.05% and 2.5%, as compared to irrad iated, vehicle-
treated controls [20]. Irradiation of skin with longwave ultra-
violet light (UV A) is known to potentiate UVB-induced ery-
thema in humans and rabbits. Photoaugmentation of epidermal 
ODC activity by UV A irradiation eit her before or after UVB 
treatment does not appear to occur [21]. 
A major clinical characteristic of psoriasis is increased epi-
dermal proliferation in both involved and uninvolved skin as 
compared to normal. Polyamine levels in psoriatic epidermis 
have been reported to be decreased as compared to normal skin 
bas·ed on nmoles of spermidine or spermine per gram tissue 
[22]. More recent determinations have shown putresc ine, sper-
midine and spermine levels to be increased in involved vs. 
uninvolved and uninvolved vs. normal skin [23]. This data is 
expressed as nmoles per J.Lg DNA, which should more accm·ately 
reflect cell numbers in the tissue samples. The ODC activity of 
involved psoriatic skin is significantly higher than that found in 
uninvolved or normal skin . Uninvolved skin has a somewhat 
higher ODC activity than normal skin . Treatment of psoriatic 
lesions with the glucocort icoid, diflorasone diacetate, reduced 
the activity of ODC by 81% [23]. 
The effects of UV A and psora! en have been studied in a 
model system. In the hairless mouse, UV A alone or topical 
treatment with 8-methoxypsoralen (8-MOP ) plus UV A at 0.9 
J /cm 2, does not increase epidermal ODC activity. However, 8-
MOP plus UVA at 3.6 J /cm2 results in a 4-fold increase in ODC 
activity 16 to 72 hT posttreatment. Similar treatment using 
anthracene plus UV A at 3.1 J /cm2 also induces ODC, bu t 
maximal enzyme activity is seen at 4 hr and declines to control 
levels by 48 hT [24]. 
In skin tumors ODC and S-adenosylmethionine decarboxyl-
ase activities are increased; squamous cell carcinomas have 
higher levels than basal cell carcinomas [25]. High levels of 
ODC activity are also induced in mouse epidermis by applica-
tion of tumor promoteTs, such as croton oil or its active com-
ponent 12-0-tetradecanoyl phorbol-13-acetate (TPA) . A single 
topical application of TPA results in a several hundred fold 
increase in ODC activity 4 to 5 hr later. The degree of stinlU-
lation of ODC is generally found to correlate closely with the 
promotional ability of various phorbol esters when compared 
on an equimola1· basis [26]. This correlation has led to the 
proposal that the induction of ornithine decarboxylase may be 
an obligatory event in skin carcinogenesis [27]. Experiments 
with TPA and vitamin A analogs have also determined that the 
order of retinoid potency for the inhibit ion of skin tumor 
promotion, or for suppression of ODC induction is identical 
[28,29]. 
More recent evidence has indicated that the relationship of 
ODC induction to tumor promotion is not as clear -cut as is 
suggested above. Mezerein, an antileukemic agent with struc-
tural similarities to TPA, induces epidermal ODC activity to 
the same extent and with the same time course as TP A. 
However, mezerein is a very weak tumor promoter with 2% or 
less the potency of TP A [30]. When weak or non promoting 
phorbol esters are applied to mouse epidermis in doses which 
stimulate 3H-thymidine labeling of DNA equally with TPA, 
comparable inductions of ODC enzyme activity are also seen 
[31]. This suggests that the induction of ODC may more accu-
rately reflect the degree of epidermal hyperplasia rather than 
tumor promotion per se. TP A has also been observed to stim-
ulate ODC activity in rat epidermis, a tissue for which it is not 
known to be a tumor promoter [15]. 
Similarities between TPA-treated epidermis and psoriatic 
epidermis led to investigation of the effects of t he anti-psoriatic 
drug anthralin in this system. Anthralin alone is a weak tumor 
promoter and stimulator of ODC activity [26]. Treatment of 
mouse skin with anthralin prior to TPA however, results in 
substantial inhibition of both tumor formation and ODC induc-
tion [32,33]. Information on the effects of the clinically used 
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crude coal tar would be of great interest but are not currently 
available. 
REGULATION OF ODC 
A number of mechanisms for the regulation of ODC have 
been proposed. Most of the research in this area has been done 
in organs other than skin, and will only be briefly discussed. 
In vivo administration of polyamines at t he time of partial 
hepatectomy, blocks the induction of ODC during liver regen-
eration in the rat [3- 5]. These data suggest regulation of ODC 
activity at the level of gene transcription. Administra tion of 
diamine inhibitors subsequent to the induction of ODC in 
regenerating liver a lso resul ts in substantial inhibition of ODC 
activity. This inhibition of ODC is associated with a decrease in 
the amount of immuno-reactive enzyme protein, and the au-
thors propose a direct inhibition of enzyme synthesis [34]. Other 
evidence indicates that prolonged treatment of liver with the 
putrescine analog, 1,3-diaminopropane, leads to the formation 
of a nondialyzeable, macromolecular inhibitor (antizyme) of 
ODC in liver [34,35]. 
Possible involvement of cycl ic nucleotides in the regulation 
of ODC has also been investigated. Alterations in the levels of 
cyclic AMP (cAMP) , cAMP-dependent protein kinase and 
ODC have been found to occur in a close temporal sequence in 
regenerating rat liver [36]. Direct evidence of phosphorylation 
or d ephosphorylation of ODC enzyme has not been reported. 
Administration of dibu tyryl cAMP or the potent phosphodies-
terase inhibitor, 1-methyl-3-isobutylxanthine (MIX) does result 
in a n increase in hepatic ODC. This increase can be abolished, 
however , by prior hypophysectomy. No increase in OPC activ-
ity is detected in livers perfused with dibutyryl cAMP or MIX 
[37]. These data indicate that the apparent induction of ODC 
by cAMP is mediated through pituitary and/or adrenal hor-
mones in the intact animal. 
The isolation of multiple, active and inactive forms of ODC 
from various tissues has raised the possibili ty of their partici-
pation in the regulation of enzyme activity. However , this 
research has all been conducted with ODC enzyme prepa1·ed in 
buffers containing no, inappropriate, or su boptimal concentra-
tion s of th iols. The appearance of multiple forms of the enzyme 
may then be an artifact of such condi tions (see "Biochemistry" 
section) . 
The relatively short biological half-life of ODC allows this 
enzyme to rapidly reflect changes in rates of protein synthesis 
and degradation. Alterations of the half-life of ODC have been 
reported under several conditions of stimulation or inhibition 
(references 3,5,34, see "Normal Skin" section) . However, li t tle 
or no research has been directed toward elucidating the mech-
anisms by which ODC is degraded. The group-specific proteases 
for pyridoxal-requiring enzymes may be involved. These pro-
teases catalyze limited proteolysis of the a po form of pyridoxal 
enzymes. It has been proposed that their function involves 
inactivation and initia tion of degradation of most, bu t possibly 
not all, pyridoxal enzymes [38]. Modulation of such a protease 
could specifically alter ODC activity levels in the absence of 
effects on total cellular protein. Pro teases for pyridoxal enzymes 
have been reported in several types of endothelial t issue [38] 
and are likely to be present in skin. 
Several studies have now indicated that ODC induction by 
diffe rent agents may occur via different mechanisms. Poso, 
Guha and J anne [39] found that the half-life of liver ODC is 
lengthened in thioacetamide- or carbon tetrachloride-treated 
rats, but not in growth hormone-treated animals. Canellakis 
and Theoharides [40] reported that the induction of ODC in 
cultured rat hepatoma cells by dibutyryl cyclic AMP or dexa-
methasone differed in time course, inhibition by polyamines 
and inhibition by Actinomycin D. Our own studies on the 
response of rat skin ODC to either ha ir plucking or TP A has 
also revealed differences in time course and sensitivity to inhi-
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bition by either Actinomycin D or indomethacin [15]. These 
data strongly support the conclusion that different inducers 
may affect different aspects of the control of ODC activity. 
SUMMARY, SPECULATIONS AND PROSPECTIVES 
FOR FUTURE RESEARCH 
Ornithine decarboxylase and the polyamines are central to 
normal and abnormal growth. The basic characteristics of the 
biochemistry of ODC seem similar in skin and other tissues-
special advantages of skin have not yet been exploited, and i.e. 
ODC and the polyamines have not been localized to particular 
cell layers or portions of the cell. The cellular localization and 
compar tmentalization of the polyamines and their transport 
between the ceJJ membrane, cytoplasm and nucleus are no 
doubt important and have not been studied in any t issues. 
Diseases have not been studied extensively; studies of diseases 
will have to be controlled for disease type and should emphasize 
combined studies of polyamines and ODC. Various stimuli will 
increase skin ODC, but more than one mechanism has already 
been found in skin and studies showing increases in ODC should 
be interpreted with that caveat. Many studies have emphasized 
transcriptional control of ODC and the antizyme concept . Stud-
ies with enucleated ceJJs produced by cytochalasin B have 
shown that cytoplasts (cytoplasm freed of nuclei) can respond 
to stimuli for growth with an increase in ODC [41]. This event 
in a non-nucleated cell must be controlled at a translational 
level and opens many previous ODC experiments to alternate 
interpretations. Since the polyamine pathway is influenced at 
many levels by structural analogues of the substrate or cofactor, 
modification of the pathway with both topical and systemic 
drugs is to be expected and those results should be of great 
interest. 
We wou ld like to t hank those colleagues who so kindly provided us 
with current abstracts, manuscripts in press, and discussions of thei1· 
unpublish ed work in progress. 
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